The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bormann-kennedy Barbara-jean Anne since 2025.
This trader's CIK number is 1635065.
At the time of last reporting, Bormann-kennedy Barbara-jean Anne was the Director of Xeris Biopharma Holdings, Inc.. (stock ticker symbol XERS).
Also see all insider trading activities at Xeris Biopharma Holdings, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | XERS | 0 | $0 | 15,000 | $106,410 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-12-12 | XERS | Sale | 15,000 | 7.09 | 106,410 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bormann-kennedy Barbara-jean Anne (Director of Xeris Biopharma Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.